×
About 1,569 results

ALLMedicine Insulin Pumps Center

Research & Reviews  591 results

Modern diabetes devices in the school setting: Perspectives from school nurses.
https://doi.org/10.1111/pedi.13015
Pediatric Diabetes REFERENCES; March CA, Nanni M et. al.

Apr 6th, 2020 - To explore the experiences, practices, and attitudes of school nurses related to modern diabetes devices (insulin pumps, continuous glucose monitors, and hybrid-closed loop systems). Semistructured interviews were conducted with 40 public school n...

Improving pediatric endocrinology trainees' knowledge about insulin pumps and continuou...
https://doi.org/10.1111/pedi.13010
Pediatric Diabetes REFERENCES; Marks BE, Waldman G et. al.

Mar 29th, 2020 - We explored the impact of TeKnO T1D, an online, case-based, spaced education curriculum about insulin pump and continuous glucose monitor (CGM) use in pediatric type 1 diabetes management. Pediatric endocrinology fellows (n = 64) were randomized t...

Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles t...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245356
Diabetes Care; Scott EM, Feig DS et. al.

Mar 26th, 2020 - To determine if temporal glucose profiles differed between 1) women who were randomized to real-time continuous glucose monitoring (RT-CGM) or self-monitored blood glucose (SMBG), 2) women who used insulin pumps or multiple daily insulin injection...

Cost, Hassle, and On-Body Experience: Barriers to Diabetes Device Use in Adolescents an...
https://doi.org/10.1089/dia.2019.0509
Diabetes Technology & Therapeutics; Messer LH, Tanenbaum ML et. al.

Mar 12th, 2020 - Background: Adolescents with diabetes have the highest A1cs of all age groups. Diabetes devices (insulin pumps and continuous glucose monitors [CGM]) can improve glycemic outcomes, and although the uptake of devices has increased, they remain unde...

REAL WORLD IMPROVEMENTS IN HYPOGLYCEMIA IN AN INSULIN-DEPENDENT COHORT WITH DIABETES ME...
https://doi.org/10.4158/EP-2019-0554
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists; Pinsker JE, Leas S et. al.

Mar 11th, 2020 - Objective: Software updatable insulin pumps, such as the t:slim X2 pump from Tandem Diabetes Care, enable access to new technology as soon as it is commercialized. The remote software update process allows for minimal interruption in therapy compa...

see more →

Guidelines  7 results

A Type 1 diabetes technology pathway: consensus statement for the use of technology in ...
https://doi.org/10.1111/dme.13933
Diabetic Medicine : a Journal of the British Diabetic Association; Choudhary P, Campbell F et. al.

Feb 18th, 2019 - In both adults and children with diabetes, technologies such as continuous subcutaneous insulin infusion using insulin pumps and continuous glucose monitoring can help improve diabetes control, reduce hypoglycaemia and improve quality of life. Acc...

Diabetes Technology: Standards of Medical Care in Diabetes—2019
http://care.diabetesjournals.org/content/42/Supplement_1/S71

Dec 17th, 2018 - Diabetes technology is the term used to describe the hardware, devices, and software that people with diabetes use to help manage blood glucose levels, stave off diabetes complications, reduce the burden of living with diabetes, and improve qualit...

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY...
https://doi.org/10.4158/PS-2017-0155
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists; Grunberger G, Handelsman Y et. al.

Mar 16th, 2018 - This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there are no randomized controlled trials or specific U.S. FDA labeling for issues in clinical pra...

JDRF Statement: Animas Exits the Insulin Pump Business - Guideline
http://www.jdrf.org/blog/2017/10/05/jdrf-statement-animas-exits-the-insulin-pump-business/
Juvenile Diabetes Research Foundation International

Oct 4th, 2017 - The choice of a pump should be made by people with diabetes and their doctors, and JDRF does not endorse products. For those Animas customers needing a new pump, the following links might be helpful.

see more →

Drugs  1 results see all →

Clinicaltrials.gov  755 results

Modern diabetes devices in the school setting: Perspectives from school nurses.
https://doi.org/10.1111/pedi.13015
Pediatric Diabetes REFERENCES; March CA, Nanni M et. al.

Apr 6th, 2020 - To explore the experiences, practices, and attitudes of school nurses related to modern diabetes devices (insulin pumps, continuous glucose monitors, and hybrid-closed loop systems). Semistructured interviews were conducted with 40 public school n...

Improving pediatric endocrinology trainees' knowledge about insulin pumps and continuou...
https://doi.org/10.1111/pedi.13010
Pediatric Diabetes REFERENCES; Marks BE, Waldman G et. al.

Mar 29th, 2020 - We explored the impact of TeKnO T1D, an online, case-based, spaced education curriculum about insulin pump and continuous glucose monitor (CGM) use in pediatric type 1 diabetes management. Pediatric endocrinology fellows (n = 64) were randomized t...

Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles t...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245356
Diabetes Care; Scott EM, Feig DS et. al.

Mar 26th, 2020 - To determine if temporal glucose profiles differed between 1) women who were randomized to real-time continuous glucose monitoring (RT-CGM) or self-monitored blood glucose (SMBG), 2) women who used insulin pumps or multiple daily insulin injection...

FDA warns patients and health care providers about potential cybersecurity concerns with certain Medtronic insulin pumps | FDA
https://www.fda.gov/news-events/press-announcements/fda-warns-patients-and-health-care-providers-about-potential-cybersecurity-concerns-certain

Mar 24th, 2020 - For Immediate Release: June 27, 2019 The U.S. Food and Drug Administration is warning patients and health care providers that certain Medtronic MiniMed insulin pumps are being recalled due to potential cybersecurity risks and recommends that patie...

Cost, Hassle, and On-Body Experience: Barriers to Diabetes Device Use in Adolescents an...
https://doi.org/10.1089/dia.2019.0509
Diabetes Technology & Therapeutics; Messer LH, Tanenbaum ML et. al.

Mar 12th, 2020 - Background: Adolescents with diabetes have the highest A1cs of all age groups. Diabetes devices (insulin pumps and continuous glucose monitors [CGM]) can improve glycemic outcomes, and although the uptake of devices has increased, they remain unde...

see more →

News  215 results

Medtronic Recalls MiniMed Insulin Pumps for Incorrect Insulin Dosing | FDA
https://www.fda.gov/medical-devices/medical-device-recalls/medtronic-recalls-minimed-insulin-pumps-incorrect-insulin-dosing

The FDA has identified this as a Class I recall, the most serious type of recall.  Use of these devices may cause serious injuries or death. Recalled Product MiniMed 600 Series Insulin Pumps Model 630G (MMT-1715) - all lots before October 2019 Mod...

FDA Issues MiniMed600 Insulin Pump Recall
https://www.medscape.com/viewarticle/925194

Feb 12th, 2020 - Medtronic is recalling certain MiniMed600 insulin pumps as part of a class I recall, the most serious kind of recall, because of a potentially fatal risk of incorrect dosing, according to a Food and Drug Administration MedWatch release. A class I ...

FDA issues MiniMed600 insulin pump recall
https://www.mdedge.com/endocrinology/article/217251/diabetes/fda-issues-minimed600-insulin-pump-recall?channel=39313
Christopher Palmer

Feb 12th, 2020 - Medtronic is recalling certain MiniMed600 insulin pumps as part of a class I recall, the most serious kind of recall, because of a potentially fatal risk of incorrect dosing, according to a Food and Drug Administration MedWatch release. Wikimedia.

FDA OKs Faster Aspart Insulin for Children With Diabetes
https://www.medscape.com/viewarticle/923435

Jan 5th, 2020 - The US Food and Drug Administration (FDA) has approved the use of the faster-acting insulin aspart (Fiasp 100 units/mL, Novo Nordisk) for pediatric patients with diabetes. Fiasp (aka "faster aspart"), a newer formulation of insulin aspart recombin...

Medtronic Recalls Remote Controllers for MiniMed Insulin Pumps for Potential Cybersecurity Risks | FDA
https://www.fda.gov/medical-devices/medical-device-recalls/medtronic-recalls-remote-controllers-minimed-insulin-pumps-potential-cybersecurity-risks

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death Other cybersecurity issues related to specified Medtronic MiniMed Insulin Pumps were communicated in the FDA...

see more →